Photobiomodulation shows promise as safe and tolerable adjunct therapy for Parkinson’s Disease, recent trial suggests Post author: Post published:December 5, 2023 Post category:uncategorized A safe and feasible treatment option for reducing the motor signs of Parkinson’s disease. You Might Also Like Yale scientists identify drug target that may alleviate joint degeneration in osteoarthritis January 3, 2024 3D nanomatrix vascular sheet model for high-throughput atherosclerosis drug testing January 12, 2024 People with both cavities and gum disease may face higher ischemic stroke risk October 23, 2025
Yale scientists identify drug target that may alleviate joint degeneration in osteoarthritis January 3, 2024